Steris plc stock (IE00BFY8C754): NYSE price consolidates around 210 USD ahead of valuation focus

Steris shares on the NYSE are trading a little above 210 USD in early June, leaving the U.S.-based sterilization and infection-prevention specialist valued at a mid-20s earnings multiple and a modest dividend yield as investors digest its recent fiscal 2026 results and look more closely at core valuation metrics.

Steris stock on the New York Stock Exchange has been changing hands a little above the 210 USD mark in early June, keeping the U.S.-listed sterilization and infection-prevention group in a market capitalization range of roughly 20.5 billion USD and implying an earnings multiple in the mid-20s alongside a modest dividend yield as investors continue to weigh the company’s most recent fiscal 2026 figures, according to Nasdaq-quoted metrics summarized by Robinhood as of 06/03/2026 and 06/04/2026.Robinhood as of 06/04/2026

According to an overview from ad-hoc-news.de that draws on U.S. trading data, Steris shares traded around 210.14 USD on the NYSE on 06/03/2026, which corresponded to a market capitalization of approximately 20.5 billion USD, a price-to-earnings ratio of about 26.5 and a dividend yield close to 1.2 percent as of that date, suggesting that the stock remains priced as a quality healthcare name with an income component rather than a high-yield play.ad-hoc-news.de overview as of 06/03/2026

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Steris plc
• Sector/industry: Healthcare equipment and services, sterilization and infection prevention
• Headquarters/country: Dublin, Ireland / United States operational base
• Core markets: North America, Europe and selected international healthcare markets
• Key revenue drivers: Medical sterilization systems, infection prevention products, healthcare consumables and related services
• Home exchange/listing venue: New York Stock Exchange (STE)
• Trading currency: USD

Steris plc: core business model

Steris focuses on providing hospitals, pharmaceutical manufacturers and other healthcare customers with sterilization platforms, infection-prevention technologies and associated consumables and services that generate recurring revenue through equipment usage, maintenance, and procedure-related product demand.

Valuation metrics and multiples for Steris plc

With the share price around the low-210 USD area at the beginning of June, Steris is trading on a price-to-earnings ratio of roughly 26.5 to 26.8 times, based on figures reported by Robinhood and summarized from Nasdaq data as of 06/03/2026 and 06/04/2026, positioning the group at a valuation premium to many diversified healthcare equipment peers that typically command lower-teens to low-20s multiples.Robinhood as of 06/04/2026

The same data set indicates that Steris offers investors a dividend yield of about 1.2 percent at current levels, which reflects a policy of returning cash while still prioritizing reinvestment and acquisitions, and the combination of a mid-20s earnings multiple and relatively low cash yield underscores that the stock continues to be valued chiefly on expectations for durable earnings growth and stable cash generation rather than near-term income, according to the ad-hoc-news.de valuation overview published on 06/03/2026.ad-hoc-news.de overview as of 06/03/2026

Conclusion

Steris remains firmly valued in the mid-20s earnings multiple range, with a share price slightly above 210 USD on the NYSE and a dividend yield of about 1.2 percent as of early June 2026, according to data compiled from Nasdaq and summarized by Robinhood and ad-hoc-news.de.

For investors watching the healthcare equipment space, these metrics frame the stock as a growth-tilted name where expectations for continued earnings expansion and steady cash flows carry more weight than near-term income, and the current valuation backdrop sets the stage for the market’s response to the company’s next operational and financial updates.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.